Nature Cancer
@NatureCancer
Nature Cancer is a journal dedicated to publishing the latest advances across all areas of cancer research.
ID:1084943471436316673
http://nature.com/natcancer 14-01-2019 22:40:55
2,1K Tweets
32,8K Followers
303 Following
Follow People
Anirban Maitra
Pancreatic cancer researcher and GI pathologist. Striving to improve the lives of patients with cancer. 🇺🇸 🇮🇳
Vivek Subbiah, MD
Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
FrezzaLab
We are a group of metabolism-lovers, focused on mitochondrial metabolism. Tweets are from Christian. https://t.co/EbWsJo6DnZ
Johanna Joyce
Professor at Univ. Lausanne 🇨🇭 @Joycelab @unil @ludwig_cancer | Cancer researcher - tumor microenvironment & immunology | Mentor, Teacher, Advocate, Mum
NatureRevClinOncol
The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.
✨ONLINE NOW Nature Cancer “Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogramming” #Glioblastoma
Read it here 👇
nature.com/articles/s4301…
💫DON’T MISS Nature Cancer “Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers” #immunotherapy
Read it here 👇
nature.com/articles/s4301…
⭐️NEW CONTENT Nature Cancer - “Associations of seven measures of biological age acceleration with frailty and all-cause mortality among adult survivors of childhood cancer in the St. Jude Lifetime Cohort”
Read it here👇
nature.com/articles/s4301…
✨NEW REVIEW ARTICLE Nature Cancer “The pleiotropic functions of reactive oxygen species in cancer”
Find it here👇
nature.com/articles/s4301…
⭐️ONLINE NOW Nature Cancer - 'Trans-Atlantic twists and turns' - a Turning Point Article describing career-defining moments by Johanna Joyce
nature.com/articles/s4301…
Explore the forefront of cancer immunotherapy at our upcoming conference in Boston with Dana-Farber. Leaders in the field will present cutting-edge research, focusing on translating fundamental knowledge to the clinic and back. Learn more: go.nature.com/CancerImm
✨ONLINE NOW Nature Cancer “Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies” #CARTcells
nature.com/articles/s4301…
✨ONLINE NOW Nature Cancer “Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies” #CARTcells
nature.com/articles/s4301…
💫DON’T MISS Nature Cancer “A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors”
nature.com/articles/s4301…
⭐️NEW CONTENT Nature Cancer “Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells”
nature.com/articles/s4301…
✨ONLINE NOW Nature Cancer “Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy” #immunotherapy
nature.com/articles/s4301…
⭐️NEW CONTENT Nature Cancer “Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols” #immunotherapy
nature.com/articles/s4301…
✨DON’T MISS Nature Cancer “Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study”
nature.com/articles/s4301…
💫ONLINE NOW Nature Cancer “Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity” #TumorImmunology
nature.com/articles/s4301…
⭐️NEW CONTENT Nature Cancer “Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial” #ClinicalTrial #BreastCancer
nature.com/articles/s4301…
📢< 1 month until abstracts are due for our upcoming Nature Conferences on #cancer #immunotherapy ! This event is co-organized w/ Dana-Farber Nature Cancer Nature Immunology Nature Rev Immunol
🗓️Deadline = April 12th
🎟️To register, submit an abstract & learn more, visit go.nature.com/CancerImm
💫DON’T MISS Nature Cancer “Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis” #metastasis
nature.com/articles/s4301…
✨ONLINE NOW Nature Cancer “The dopamine transporter antagonist vanoxerine inhibits G9a and suppresses cancer stem cell functions in colon tumors”
nature.com/articles/s4301…